Atacand 8mg, 16mg or 32mg Tablet
PDF Leaflet Revision Date: 13 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Mild to moderate hypertension and heart failure.
Dosage (summary)
Initial: 8 mg once daily; Maintenance: 8-16 mg once daily; Max: 32 mg once daily.
Onset of Action / Duration
Onset: 2 hours, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in second and third trimesters; not recommended during first trimester.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
Contraindications
- Hypersensitivity
- Severe renal impairment
- Pregnancy
- Severe hepatic impairment
- Bilateral renal artery stenosis
Common side effects
- Dizziness
- Headache
- Respiratory infection
Counselling Points
- Take once daily with or without food
- Monitor blood pressure regularly
- Avoid potassium supplements
Serious warnings
- Risk of hypotension
- Hyperkalaemia
- Renal impairment
Important Disclaimer
The Atacand 8mg, 16mg or 32mg Tablet professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
